We are live on ! Find out more
VSTM icon

Verastem

59 hedge funds and large institutions have $19.6M invested in Verastem in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

14% more capital invested

Capital invested by funds: $17.1M → $19.6M (+$2.47M)

11% more funds holding

Funds holding: 5359 (+6)

0.16% more ownership

Funds ownership: 1.87%2.03% (+0.16%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

29% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 21

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
59
Holders Change
+6
Holders Change %
+11.32%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
15
Reduced
21
Closed
9
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K

VSTM Hedge Fund Activity: Q2 2017 in Review

59 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q2 2017, worth a combined $19.6M — up 14% from $17.1M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new VSTM positions and 9 closed out — a net gain of 6 holders — while 15 added to existing stakes and 21 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.43M. The largest seller was Fidelity Investments, cutting an estimated $955K.

  • 59 institutional investors held Verastem (VSTM) as of Q2 2017, up from 53 in Q1 2017.
  • Funds reported $19.6M of Verastem stock for Q2 2017, up 14% quarter-over-quarter.
  • 15 funds opened new Verastem positions in Q2 2017 and 9 closed out, a net change of +6 holders.
  • The largest Verastem buyer in Q2 2017 was Renaissance Technologies, an estimated $1.43M added.
  • The largest Verastem seller in Q2 2017 was Fidelity Investments, an estimated $955K sold.

Based on aggregated 13F filings for Q2 2017.